AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sugaryl-M2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Solveig Lifesciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Sugaryl-M2 Tablet ER

Diabetol Duo ER tablets are a dual-action antidiabetic medication, combining two agents to manage type 2 diabetes in adults. This formulation effectively regulates blood glucose. Diabetol Duo ER should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn to recognize symptoms like sweating, lightheadedness, headache, and tremors, and know how to treat it. Maintain regular meals and carry a rapid-acting glucose source. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Sugaryl-M2 Tablet ER

Managing type 2 diabetes

Major Benefits of Sugaryl-M2 Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Sugaryl-M2 Tablet ER whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Sugaryl-M2 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Sugaryl-M2 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sugaryl-M2 Tablet ER whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Sugaryl-M2 Tablet ER works:

Sugaryl-M2 Extended-Release tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose output, inhibiting intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sugaryl-M2 Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Sugaryl-M2 Tablet might pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Sugaryl-M2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity associated with this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Sugaryl-M2 Tablet ER, potentially requiring dosage modification. Consult your physician for guidance. Sugaryl-M2 Tablet ER is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Sugaryl-M2 Tablet ER to patients with hepatic impairment; dosage modification may be necessary. Consult a physician. In individuals with mild to moderate liver disease, initiate Sugaryl-M2 Tablet ER therapy at a reduced dosage; avoid use in those with severe hepatic dysfunction.

What if you forget to take Sugaryl-M2 Tablet ER :

Should you forget a dose of Sugaryl-M2 Tablet ER, take it immediately if you remember. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Sugaryl-M2 Tablet ER

LabelValue
Developing Habits No.
Type of Treatment Diabetes Treatment

FAQs on Sugaryl-M2 Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sugaryl-M2 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sugaryl-M2 Tablet ER and seek immediate medical attention.
Sugaryl-M2 ER tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 DM.
Sugaryl-M2 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Sugaryl-M2 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate these risks, supplemental vitamin B12 is recommended annually by some researchers.
Hypoglycemia (low blood sugar) is a possible side effect of Sugaryl-M2 Tablet ER. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Sugaryl-M2 ER tablets and alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Sugaryl-M2 Tablet ER
44
MRP 54
18% off